Clinical results from transplanting incompatible live kidney donor/recipient pairs using kidney paired donation

Department of Surgery, Columbia University, New York, New York, United States
JAMA The Journal of the American Medical Association (Impact Factor: 30.39). 11/2005; 294(13):1655-63. DOI: 10.1001/jama.294.13.1655
Source: PubMed

ABSTRACT First proposed 2 decades ago, live kidney paired donation (KPD) was considered a promising new approach to addressing the shortage of organs for transplantation. Ethical, administrative, and logistical barriers initially proved formidable and prevented the implementation of KPD programs in the United States.
To determine the feasibility and effectiveness of KPD for the management of patients with incompatible donors.
Prospective series of paired donations matched and transplanted from a pool of blood type or crossmatch incompatible donors and recipients with end-stage renal disease (6 conventional and 4 unconventional KPD transplants) at a US tertiary referral center (between June 2001 and November 2004) with expertise in performing transplants in patients with high immunologic risk.
Kidney paired donation and live donor renal transplantation.
Patient survival, graft survival, serum creatinine levels, rejection episodes.
A total of 22 patients received transplants through 10 paired donations including 2 triple exchanges at Johns Hopkins Hospital. At a median follow-up of 13 months (range, 1-42 months), the patient survival rate was 100% and the graft survival rate was 95.5%. Twenty-one of the 22 patients have functioning grafts with a median 6-month serum creatinine level of 1.2 mg/dL (range, 0.8-1.8 mg/dL) (106.1 micromol/L [range, 70.7-159.1 micromol/L]). There were no instances of antibody-mediated rejection despite the inclusion of 5 patients who were highly sensitized to HLA antigens due to previous exposure to foreign tissue. Four patients developed acute cellular rejection (18%).
This series of patients who received transplants from a single-center KPD pool provides evidence that recipients with incompatible live donors, even those with rare blood type combinations or high degrees of HLA antigen sensitization, can receive transplants through KPD with graft survival rates that appear to be equivalent to directed, compatible live donor transplants. If these results can be generalized, broader availability of KPD to the estimated 6000 patients with incompatible donors could result in a large expansion of the donor pool.

  • Source
    • "He described use of Eculizumab and splenectomy in combination for resistant AMR but emphasized urgency (within 24 h of AMR onset) to achieve maximum benefit (Orandi et al., 2014b). Despite risks associated with AiT, there is survival benefit compared to staying on dialysis (Montgomery et al., 2005). He confirmed similar findings to Dr Loupy and Professor Higgins of poor graft failure related to antibody strength, defined by MFI, and presence of positive CDC cross-match with over 60% graft failure within 5 years post-transplantation and a hazard ratio of 5.0 for graft loss in cases CDCpositive pretransplantation (P < 0.001). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The 3rd International Transplant Conference took place on 31st October and 1st November 2014 at the University of Warwick, Coventry, UK. Key focal points of the meeting were the exploration of the molecular basis of antibody-antigen interactions and their relation to clinical practice and to share experiences and knowledge regarding strategies to transplant the 'high-risk' patient. In addition, lively debate sessions were hosted where controversial clinical and immunological themes were discussed by leading experts in the field. © 2015 John Wiley & Sons Ltd.
    International Journal of Immunogenetics 02/2015; 42(2). DOI:10.1111/iji.12184 · 1.34 Impact Factor
  • Source
    • "The advantages with use of organs from DDs are the elimination of the risk to the donor and that an organ can be retrieved together with a large vascular pedicle containing central and vital vessels such as the aorta, vena cava and iliac vessels. Live donation (LD) is practiced in renal transplantation, partial liver transplantation (Montgomery et al., 2005; Olsen and Brown, 2008) and less frequently as segmental pancreas or lung transplantation "
    [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this review is to summarize the state-of the-art methods that are used in clinical organ transplantation today, as well as the major findings of recent experimental uterus transplantation (UTx) research regarding organ donation/retrieval, ischemic preservation, surgical techniques for anastomosis, immunosuppression and pregnancy. Absolute uterine factor infertility lacks treatment despite the major developments in infertility treatment and assisted reproduction. Concerning uterine factor infertile patients, genetic motherhood is only possible through gestational surrogacy. The latter can pose medical, ethical and legal concerns such as lack of control of life habits during surrogate pregnancy, economic motives for women to become surrogate mothers, medical/psychological pregnancy-related risks of the surrogate mother and uncertainties regarding the mother definition. Thus, surrogacy is non-approved in large parts of the world. Recent advances in the field of solid organ transplantation and experimental UTx provide a favourable and safe background in a scenario in which a human clinical UTx trial can take place. Protocols based on animal research over the last decade are described with a view to providing a scientifically guided approach to human UTx as an experimental procedure in the future.
    Molecular Human Reproduction 09/2011; 18(2):68-78. DOI:10.1093/molehr/gar055 · 3.48 Impact Factor
  • Source
    • "Nevertheless, there are numerous reports favoring the benefit of kidney exchanges. From the medical literature, survival rates up to 100% are reported in a sample including 10 two-way, paired donations [8]. Further benefits in terms of total saved lives can be found where larger than two-way exchanges are considered [14]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In kidney exchanges, hospitals share patient lists and receive transplantations. A kidney-paired donation (KPD) mechanism needs to promote full sharing of information about donor-patient pairs, and identify a Pareto efficient outcome that also satisfies participation constraints of hospitals. We introduce a random graph model of the KPD exchange and then fully characterize the structure of the efficient outcome and the expected number of transplantations that can be performed. Random graph theory allows early experimental results to be explained analytically, and enables the study of participation incentives in a methodological way. We derive a square-root law between the welfare gains from sharing patient-donor pairs in a central pool and the individual sizes of hospitals, illustrating the urgent need for the nationwide expansion of such programs. Finally, we establish through theoretical and computational analysis that enforcing simple individual rationality constraints on the outcome can mitigate the negative impact of strategic behavior by hospitals.
    Proceedings 12th ACM Conference on Electronic Commerce (EC-2011), San Jose, CA, USA, June 5-9, 2011; 01/2011
Show more


1 Download
Available from